Competing risks of mortality by PAM50 intrinsic subtype: BC tamoxifen-treated cohort.
Judy-Anne W. Chapman
No relevant relationships to disclose
Shuzhen Liu
Research Funding - NanoString Technologies
Samuel Leung
No relevant relationships to disclose
Torsten O. Nielsen
Consultant or Advisory Role - Bioclassifier; NanoString Technologies
Stock Ownership - Bioclassifier
Research Funding - NanoString Technologies
Other Remuneration - NanoString Technologies